Beyond HRT: What to Offer the Woman Who Can’t, or Won’t, Take Hormones

The question isn’t only who needs hormones. Dr Roza Olyai and Dr Parikshit Tank show how to care for women who can’t or won’t take them, and why the conversation must start before the last period.

Who should skip hormones, and who is borderline

Dr Olyai’s exclusion list: women beyond 60 or ten years past menopause, hormone-dependent cancers, obesity, and prior thromboembolism, MI or heart disease. Dr Tank noted rising NCDs will enlarge this group. Below 40 (surgical menopause or POI), estrogen continues until the natural age of menopause. At 40–44, hormones suit only severe symptoms without obesity, diabetes or metabolic syndrome; otherwise prioritise diet, vitamin D3 and bone health. Her rule: tailor every patient.

Hot flushes, sleep and mood

Venlafaxine 37.5 mg, titrated to a maximum of 75 mg daily, covers flushes, insomnia and low mood, with nausea, constipation and BP as watch-points. Gabapentin 100 mg helps sleep, and SSRIs need caution with tamoxifen because of cytochrome interactions. Low mood often follows sleepless nights, so she treats flushes first, adds cotton clothing, cool rooms and no caffeine or alcohol, and runs patient support groups. If SNRIs fall short, escalate; referral is nothing to feel shy about.

Genitourinary and sexual health

After excluding abnormal bleeding, local estriol is her first choice, and she has used it to settle recurrent UTIs in women who had already seen several specialists. Probiotics, prebiotics, root-bark phytoestrogens and neutral silicone-based gels come next. On libido, “Women are 70% not able to speak about it,” so ask about dyspareunia directly, then offer local estrogen, lubricants, Kegels and counselling for the husband.

Bone, fatigue and baseline tests

From about 44 until a few years beyond the final period lies a “window of opportunity”: DEXA, calcium, vitamin D3, brisk walking, yoga and adequate protein. Established osteoporosis warrants orthopaedic referral, since hip fracture shortens survival. Her baseline panel: CBC, liver, renal and lipid profiles, HbA1c, vitamin D, calcium, homocysteine, urine routine, pelvic ultrasound, Pap with HPV DNA and DEXA, with lipid abnormalities and ECG or echo escalated to the physician.

Why non-hormonal appeals

Safety is the draw: no breast or uterine cancer anxiety, and less surveillance, as Dr Parikshit puts it. Yet Dr Olyai still wants blood tests and DEXA, and poor response should prompt a rethink of drug, dose and diet, including phytoestrogen-rich flaxseed and soy.

Ask about menopause rather than wait for it. Risk-stratify, treat symptoms with the safest option, use local estrogen where appropriate, and begin protecting bone before the final period.